A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): Primary analysis of Radiation Therapy Oncology Group (RTOG) 0515

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 435-441.e1

  Bradley, Jeffrey ^a   Bae, Kyounghwa ^b   Choi, Noah ^c   Forster, Ken ^d   Siegel, Barry A ^a   Brunetti, Jacqueline ^e   Purdy, James ^f   Faria, Sergio ^g   Vu, Toni ^h   Thorstad, Wade ^a   Choy, Hak ⁱ  

^a USA   (United States)

^b RTOG   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e Holy Name Medical Center   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h NOTRE DAME HOSPITAL   (Canada)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

FDG PET; Lung cancer; Mediastinal nodal staging; mediastinum

Indexed keywords

BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; DISEASES; FAILURE ANALYSIS; ONCOLOGY; POINT CONTACTS; POSITRON EMISSION TOMOGRAPHY; TUMORS;

BONFERRONI ADJUSTMENT; FDG PET; LUNG CANCER; MEDIASTINAL NODAL STAGING; MEDIASTINUM; NON SMALL CELL LUNG CANCER; POSITRON EMISSION TOMOGRAPHY (PET); RADIATION THERAPY ONCOLOGY GROUPS;

RADIOTHERAPY;

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SCINTISCANNING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DOSIMETRY; ESOPHAGUS; FEMALE; FOLLOW UP; GROSS TUMOR VOLUME; HUMAN; INTERMETHOD COMPARISON; LUNG; LUNG NON SMALL CELL CANCER; LUNG SCINTISCANNING; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; TREATMENT FAILURE; TREATMENT PLANNING; TUMOR VOLUME;

EID: 83955164326     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.09.033     Document Type: Article

References (19)

1. D. Morgensztern, B. Goodgame, and M.Q. Baggstrom The effect of FDG-PET on the stage distribution of non-small cell lung cancer J Thorac Oncol 3 2008 135 139
2. M. MacManus, U. Nestle, and K.E. Rosenzweig Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
3. F.L. Greene, D.L. Page, and I.D. Fleming AJCC Cancer Staging Manual 6th edition 2002 Springer-Verlag New York
4. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
5. E.M. Toloza, L. Harpole, and D.C. McCrory Noninvasive staging of non-small cell lung cancer: a review of the current evidence Chest 123 2003 137S 146S
6. U. Nestle, S. Kremp, and A.L. Grosu Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives Radiother Oncol 81 2006 209 225
7. U. Nestle, K. Walter, and S. Schmidt 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis Int J Radiat Oncol Biol Phys 44 1999 593 597
8. J.D. Kiffer, S.U. Berlangieri, and A.M. Scott The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer Lung Cancer 19 1998 167 177
9. L.J. Vanuytsel, J.F. Vansteenkiste, and S.G. Stroobants The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer Radiother Oncol 55 2000 317 324
10. M.T. Munley, L.B. Marks, and C. Scarfone Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: Challenges and prospects Lung Cancer 23 1999 105 114
11. E. Brianzoni, G. Rossi, and S. Ancidei Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume Eur J Nucl Med Mol Imaging 32 2005 1392 1399
12. V. Kalff, R.J. Hicks, and M.P. MacManus Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: A prospective study J Clin Oncol 19 2001 111 118
13. M.P. MacManus, R.J. Hicks, and J.P. Matthews High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: Implications for radical radiation therapy Int J Radiat Oncol Biol Phys 50 2001 287 293
14. K. Mah, C.B. Caldwell, and Y.C. Ung The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study Int J Radiat Oncol Biol Phys 52 2002 339 350
15. P. Giraud, D. Grahek, and F. Montravers CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers Int J Radiat Oncol Biol Phys 49 2001 1249 1257
16. Y.E. Erdi, K. Rosenzweig, and A.K. Erdi Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET) Radiother Oncol 62 2002 51 60
17. J. Bradley, W.L. Thorstad, and S. Mutic Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 59 2004 78 86
18. E. Deniaud-Alexandre, E. Touboul, and D. Lerouge Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 63 2005 1432 1441
19. S.L. Faria, S. Menard, and S. Devic Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings Int J Radiat Oncol Biol Phys 70 2008 1035 1038